LYOTROPIC LIQUID CRYSTALLINE SYSTEM FOR EFFECTIVE TOPICAL DELIVERY OF TOLNAFTATE
DOI:
https://doi.org/10.22270/ajprd.v6i3.349Keywords:
Tolnaftate, LyotropicLiquid crystals, Brij 78, Silicon oil, AnisotropicAbstract
The present investigation deals with the formulation, optimization and evaluation of liquid crystalline cream of Tolnaftate. Brij-78 used as a surfactant, Cetostearyl alcohol was used as a co-surfactant and Silicon oil as a oil phase. Liquid crystalline cream system, has a potential for efficient delivery of Tolnaftate (1%), as topical dermal drug delivery system. The liquid crystalline system enhance the diffusion of water insoluble drug Tolnaftate through the skin for effective result. Liquid crystals (LC) are substances that flow like liquids but maintain some of the ordered structure characteristics of crystalline solids. Based on the ways that LCs are generated, they can be classified into two types 1) Thermotropic LCS and 2) Lyotropic LCs. Incorporation of the drug in liquid crystal increased its antimycotic activity against different antifungal microorganisms. Used surfactant enhance the penetration of drug and also improve the solubility of drug. The objective of this study was to increase the diffusion coefficient of drug through the formulation, and also to improve the availability of drug at the site of action. The prepared liquid crystalline cream exhibited the expected, viscosity, drug content, pH, spreadability, in vitro drug release and in vitro antimycotic inhibitory activity. Liquid crystalline cream for tolnaftate was found to be stable cream. It was found to have better in vitrorelease profile characteristics, and in vitro antimycotic activity, it can be concluded that the formulation F5 has better potential of antimicrobial activity and to enhance the diffusion of drug through the cream.
Downloads
References
2. Nesseem DI. Formulation and Evaluation of Itraconazole via Liquid Crystal For Topical Delivery System. Journal of Pharmaceutical and Biomedical Analysis 2001; 26: 387–399.
3. Munagala GR, Akki R., Kumar PD, Formulation and Evalution of Tolnaftate Loaded Topical Niosomal Gel, ThePharma Innovation Journal 2017; 6(8): 29-34.
4. Purushotham R.K ,Khaliq K, Kharat S.S, Sagare P,Patil S.K. Preparation and Evaluation O/W Cream for Skin Psoriasis 2010; 1(3): 1-11
5. Yadav S, Wairkar S,Invally M, Ranade S. Topical EmulgeloF Tolnaftate With Penetration Enhancer: Development, Characterization and Antifungal Activity, Indian Journal of Medical Research and Pharmaceutical Sciences 2017;4(10), 28-35.
6. Meghana G, Narayana RK, Siddhartha VT, Raviteja G, Saikrishna R C, Ganesh GNK. Formulation and Evaluation of Tolnaftate Loaded Topical Liposomal Gel for Effective Skin Drug Delivery to Treat Fungal Diseases, Journal of Chemical and Pharmaceutical Research, 2014; 6(10): 856-866.
7. Determination Of Minimum Inhibitory Concentrations (Mics) Of Antibacterial Agents By Agar Dilution, Eucast Definitive Document E.Def 3.1, 2000; 6 : 509-515
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).